Adjunctive therapies in the treatment of acute coronary syndromes

Wayne L. Miller, Guy S. Reeder

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Survival after myocardial infarction has been improving steadily in recent decades, in part because of more effective adjunctive medical therapies. However, the issue of underutilization of effective medical therapies remains. Adjunctive therapy for acute myocardial infarction should include aspirin, β-adrenergic blocking agents, angiotensin-converting enzyme inhibitors, and lipid-lowering agents, all of which improve survival in the treatment and secondary prevention of myocardial infarction. This review presents the current knowledge supporting the use of specific adjunctive pharmacologic agents and also discusses the current status of other agents that are emerging or controversial.

Original languageEnglish (US)
Pages (from-to)391-405
Number of pages15
JournalMayo Clinic Proceedings
Volume76
Issue number4
StatePublished - 2001

Fingerprint

Acute Coronary Syndrome
Myocardial Infarction
Adrenergic Antagonists
Therapeutics
Secondary Prevention
Angiotensin-Converting Enzyme Inhibitors
Aspirin
Lipids

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Miller, W. L., & Reeder, G. S. (2001). Adjunctive therapies in the treatment of acute coronary syndromes. Mayo Clinic Proceedings, 76(4), 391-405.

Adjunctive therapies in the treatment of acute coronary syndromes. / Miller, Wayne L.; Reeder, Guy S.

In: Mayo Clinic Proceedings, Vol. 76, No. 4, 2001, p. 391-405.

Research output: Contribution to journalReview article

Miller, WL & Reeder, GS 2001, 'Adjunctive therapies in the treatment of acute coronary syndromes', Mayo Clinic Proceedings, vol. 76, no. 4, pp. 391-405.
Miller, Wayne L. ; Reeder, Guy S. / Adjunctive therapies in the treatment of acute coronary syndromes. In: Mayo Clinic Proceedings. 2001 ; Vol. 76, No. 4. pp. 391-405.
@article{d402168a8f564b98904b514701ab1b99,
title = "Adjunctive therapies in the treatment of acute coronary syndromes",
abstract = "Survival after myocardial infarction has been improving steadily in recent decades, in part because of more effective adjunctive medical therapies. However, the issue of underutilization of effective medical therapies remains. Adjunctive therapy for acute myocardial infarction should include aspirin, β-adrenergic blocking agents, angiotensin-converting enzyme inhibitors, and lipid-lowering agents, all of which improve survival in the treatment and secondary prevention of myocardial infarction. This review presents the current knowledge supporting the use of specific adjunctive pharmacologic agents and also discusses the current status of other agents that are emerging or controversial.",
author = "Miller, {Wayne L.} and Reeder, {Guy S.}",
year = "2001",
language = "English (US)",
volume = "76",
pages = "391--405",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "4",

}

TY - JOUR

T1 - Adjunctive therapies in the treatment of acute coronary syndromes

AU - Miller, Wayne L.

AU - Reeder, Guy S.

PY - 2001

Y1 - 2001

N2 - Survival after myocardial infarction has been improving steadily in recent decades, in part because of more effective adjunctive medical therapies. However, the issue of underutilization of effective medical therapies remains. Adjunctive therapy for acute myocardial infarction should include aspirin, β-adrenergic blocking agents, angiotensin-converting enzyme inhibitors, and lipid-lowering agents, all of which improve survival in the treatment and secondary prevention of myocardial infarction. This review presents the current knowledge supporting the use of specific adjunctive pharmacologic agents and also discusses the current status of other agents that are emerging or controversial.

AB - Survival after myocardial infarction has been improving steadily in recent decades, in part because of more effective adjunctive medical therapies. However, the issue of underutilization of effective medical therapies remains. Adjunctive therapy for acute myocardial infarction should include aspirin, β-adrenergic blocking agents, angiotensin-converting enzyme inhibitors, and lipid-lowering agents, all of which improve survival in the treatment and secondary prevention of myocardial infarction. This review presents the current knowledge supporting the use of specific adjunctive pharmacologic agents and also discusses the current status of other agents that are emerging or controversial.

UR - http://www.scopus.com/inward/record.url?scp=0035082271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035082271&partnerID=8YFLogxK

M3 - Review article

C2 - 11322355

AN - SCOPUS:0035082271

VL - 76

SP - 391

EP - 405

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 4

ER -